Reform of European Medicines Agency Fee System

by name voted on 12.12.2023

Summary

This proposal aims to simplify and modernize how the European Medicines Agency (EMA) is funded through fees and charges. It introduces cost-based pricing, inflation adjustments, and support for research sectors like academia and small businesses.

9 12.12.2023

Other

health

economy

finance

science

pharmacy

administrative law

public administration

business and competition

Key points

Simplification of the existing legal framework governing the funding of the European Medicines Agency.
Implementation of a cost-based fee structure to ensure the Agency has sufficient resources for its health protection tasks.
Introduction of a mechanism to adjust fees and charges in line with inflation rates.
Provision of fee reductions and waivers to support academic research, non-profit organizations, and small businesses.

Vote

PPE

S&D

Renew

Verts/ALE

ECR

ID

NI

The Left

Total

Speeches

1 Speech in total

Pro

Contra

Cristian-Silviu BUŞOI

Cristian-Silviu BUŞOI

PPE

0:12 min

8.2. Fees and charges payable to the European Medicines Agency ***I (vote)

Documents (PDFs)

DRAFT REPORT on the proposal for a regulation of the European Parliament and of the Council of the Council on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) 658/2014 of the European Parliament and of the Council REPORT on the proposal for a regulation of the European Parliament and of the Council of the Council on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) 658/2014 of the European Parliament and of the Council Opinion on the Commission proposal on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) 658/2014 of the European Parliament and of the Council Fees and charges payable to the European Medicines Agency Fees and charges payable to the European Medicines Agency

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.